Fernandes Carlos Antônio de Carvalho, Pereira Jéssica Ruiz, Souza Vinícius Oliveira, de Figueiredo Ana Cristina Silva, Viana Joao Henrique Moreira, Siqueira Luiz Gustavo Bruno, Palhao Miller Pereira
Universidade Jose Do Rosario Vellano, Alfenas, MG, 37130-000, Brazil; Biotran Biotecnologia, Alfenas, MG, 37130-000, Brazil.
Universidade Jose Do Rosario Vellano, Alfenas, MG, 37130-000, Brazil.
Theriogenology. 2021 Jun;167:61-66. doi: 10.1016/j.theriogenology.2021.03.009. Epub 2021 Mar 18.
The aim of this study was to evaluate the outcomes of an early resynchronization protocol (Resynch) initiated at different timepoints after timed artificial insemination (TAI) and with unknown pregnancy status. Holstein cows (n = 164) were submitted to the following TAI protocol: D0, insertion of an intravaginal progesterone (P4) device and 2 mg im estradiol benzoate (EB); D8, removal of P4 device and treatment with 0.5 mg im sodium cloprostenol (PGF); D9, 0.1 mg im Lecirelin (LEC); and D10, TAI1. Cows were then randomly assigned to Resynch protocols starting either on day 20 (Resynch20D, n = 82) or 25 after TAI1 (Resynch25D, n = 82) with the insertion of a new P4 device and EB treatment. In both groups, P4 device was removed on day 8 after the beginning of Resynch, the same day of pregnancy diagnosis by ultrasonography. In pregnant cows there was no further action. Non-pregnant cows were treated with 0.5 mg im PGF, had a blood sample collected for serum P4 analysis and we measured and recorded the size of the largest follicle and the presence or absence of a corpus luteum (CL). One day later, cows were treated with 0.1 mg im LEC and TAI2 occurred 12-14 h later. The diameter of the largest follicle and serum P4 were compared between groups by ANOVA for the main effects of treatment, presence of a CL, and their interaction, whereas pregnancy per artificial insemination (P/AI) and the percentage of cows with a CL on the day of ultrasonography were analyzed using the Chi-square test. Follicle diameter on day 8 of Resynch was greater for cows in the Resynch20D group compared with Resynch25D (15.9 ± 3.9 vs 12.2 ± 2.5 mm, respectively; P = 0.046). The Resynch25D group had a greater percentage of cows with a CL (51.9 vs 18.9%, respectively; P = 0.0008) and higher serum P4 (2.8 ± 1.1 vs 1.7 ± 0.8 ng/mL; P = 0.041) at the end of the protocol compared with Resynch20D. P/AI at TAI1 was 35.4 and 36.6% (P > 0.10) for cows enrolled in Resynch20D and Resynch25D groups, respectively. P/AI to TAI2, after Resynch protocols, was greater in Resynch25D than Resynch20D (44.2 vs 22.6%, respectively; P < 0.05). In conclusion, starting an early resynchronization protocol 25 days after TAI increases P/AI compared with starting 20 days after TAI, and this was associated with a presumed greater proportion of cows with a functional CL at the moment of P4 device removal.
本研究的目的是评估在定时人工授精(TAI)后不同时间点启动且妊娠状态未知的早期再同步方案(Resynch)的效果。将164头荷斯坦奶牛按照以下TAI方案进行处理:第0天,插入阴道内孕酮(P4)装置并肌肉注射2mg苯甲酸雌二醇(EB);第8天,取出P4装置并肌肉注射0.5mg氯前列醇钠(PGF);第9天,肌肉注射0.1mg来曲瑞林(LEC);第10天,进行TAI1。然后将奶牛随机分配到再同步方案中,分别在TAI1后第20天(Resynch20D组,n = 82)或第25天(Resynch25D组,n = 82)开始,插入新的P4装置并进行EB处理。在两组中,再同步开始后第8天取出P4装置,同一天通过超声进行妊娠诊断。对于怀孕的奶牛,不再采取进一步措施。未怀孕的奶牛肌肉注射0.5mg PGF,采集血样进行血清P4分析,并测量和记录最大卵泡的大小以及黄体(CL)的有无。一天后,给奶牛肌肉注射0.1mg LEC,12 - 14小时后进行TAI2。通过方差分析比较两组间最大卵泡直径和血清P4,分析处理、CL的存在及其相互作用的主要影响,而使用卡方检验分析每次人工授精的妊娠率(P/AI)以及超声检查当天有CL的奶牛百分比。与Resynch25D组相比,Resynch20D组再同步第8天的奶牛卵泡直径更大(分别为15.9±3.9mm和12.2±2.5mm;P = 0.046)。与Resynch20D组相比,Resynch25D组在方案结束时具有CL的奶牛百分比更高(分别为51.9%和18.9%;P = 0.0008),血清P4更高(2.8±1.1 vs 1.7±0.8ng/mL;P = 0.041)。Resynch20D组和Resynch25D组奶牛在TAI1时的P/AI分别为35.4%和36.6%(P>0.10)。再同步方案后,TAI2的P/AI在Resynch25D组高于Resynch20D组(分别为44.2%和22.6%;P<0.05)。总之,与TAI后20天开始相比,TAI后25天开始早期再同步方案可提高P/AI,这与P4装置取出时推测具有功能性CL的奶牛比例更高有关。